Terms: = Thyroid cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Diagnosis
23 results:
1. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
2. Identification of BRAF, CCND1, and myc mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
3. Melanotic medullary thyroid carcinoma: A case report with review of the literature.
Brzezinska KA; Bhardwaj S; Teng MS; Si Q; Sun J; Westra WH; Zakowski MF; Szporn AH
Diagn Cytopathol; 2023 Jan; 51(1):E14-E20. PubMed ID: 36056712
[TBL] [Abstract] [Full Text] [Related]
4. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings.
Khanna L; Prasad SR; Yedururi S; Parameswaran AM; Marcal LP; Sandrasegaran K; Tirumani SH; Menias CO; Katabathina VS
Radiographics; 2021; 41(3):876-894. PubMed ID: 33891523
[TBL] [Abstract] [Full Text] [Related]
5. SHCBP1 Promotes Papillary thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness.
Geng H; Guo M; Xu W; Zang X; Wu T; Teng F; Wang Y; Liu X; Wang X; Sun Q; Liang J
Front Endocrinol (Lausanne); 2020; 11():613879. PubMed ID: 33716952
[TBL] [Abstract] [Full Text] [Related]
6. circRNA_0005529 facilitates growth and metastasis of gastric cancer via regulating miR-527/Sp1 axis.
Zhang X; Yang H; Jia Y; Xu Z; Zhang L; Sun M; Fu J
BMC Mol Cell Biol; 2021 Jan; 22(1):6. PubMed ID: 33472586
[TBL] [Abstract] [Full Text] [Related]
7. A Multicenter Retrospective Study of 58 Patients With Primary thyroid Diffuse Large B Cell Lymphoma.
Yi J; Yi P; Wang W; Wang H; Wang X; Luo H; Fan P
Front Endocrinol (Lausanne); 2020; 11():542. PubMed ID: 32982962
[No Abstract] [Full Text] [Related]
8. Regulators of glucose uptake in thyroid cancer cell lines.
Heydarzadeh S; Moshtaghie AA; Daneshpoor M; Hedayati M
Cell Commun Signal; 2020 Jun; 18(1):83. PubMed ID: 32493394
[TBL] [Abstract] [Full Text] [Related]
9. miR-145 promotes miR-133b expression through c-myc and DNMT3A-mediated methylation in ovarian cancer cells.
Li J; Zhang S; Zou Y; Wu L; Pei M; Jiang Y
J Cell Physiol; 2020 May; 235(5):4291-4301. PubMed ID: 31612498
[TBL] [Abstract] [Full Text] [Related]
10. Down-Regulation of Nfatc1 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Prostate cancer Cells.
Liu Y; Liang T; Qiu X; Ye X; Li Z; Tian B; Yan D
Med Sci Monit; 2019 Feb; 25():1572-1581. PubMed ID: 30817743
[TBL] [Abstract] [Full Text] [Related]
11. Identification of novel biomarker and therapeutic target candidates for diagnosis and treatment of follicular carcinoma.
Lai X; Umbricht CB; Fisher K; Bishop J; Shi Q; Chen S
J Proteomics; 2017 Aug; 166():59-67. PubMed ID: 28709933
[TBL] [Abstract] [Full Text] [Related]
12. Identification of microRNAs associated with medullary thyroid carcinoma by bioinformatics analyses.
Fu X; Fang J; Lian M; Zhong Q; Ma H; Feng L; Wang R; Wang H
Mol Med Rep; 2017 Jun; 15(6):4266-4272. PubMed ID: 28487941
[TBL] [Abstract] [Full Text] [Related]
13. Burkitt lymphoma presenting as a mass in the thyroid gland: a clinicopathologic study of 7 cases and review of the literature.
Quesada AE; Liu H; Miranda RN; Golardi N; Billah S; Medeiros LJ; Jaso JM
Hum Pathol; 2016 Oct; 56():101-8. PubMed ID: 27257042
[TBL] [Abstract] [Full Text] [Related]
14. Identification of Novel Biomarker and Therapeutic Target Candidates for diagnosis and Treatment of Follicular Adenoma.
Lai X; Chen S
Cancer Genomics Proteomics; 2015; 12(6):271-81. PubMed ID: 26543076
[TBL] [Abstract] [Full Text] [Related]
15. Nuclear C-myc expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer.
Zeng W; Sun H; Meng F; Liu Z; Xiong J; Zhou S; Li F; Hu J; Hu Z; Liu Z
Int J Clin Exp Pathol; 2015; 8(2):1878-88. PubMed ID: 25973080
[TBL] [Abstract] [Full Text] [Related]
16. Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker.
Hao Z; Zhang H; Cowell J
Tumour Biol; 2012 Jun; 33(3):723-30. PubMed ID: 22170434
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Zhan S; Xie K; Li QQ
Anticancer Res; 2011 Oct; 31(10):3433-40. PubMed ID: 21965758
[TBL] [Abstract] [Full Text] [Related]
18. [Advances in the diagnosis of ENT tumors in childhood].
Muñoz Borge F; González Alonso J; Galera Ruiz H; Delgado Moreno F; Galera Davidson H
An Pediatr (Barc); 2003 May; 58(5):456-63. PubMed ID: 12724079
[TBL] [Abstract] [Full Text] [Related]
19. Sarcoma and thyroid disorders: a common etiology?
Merimsky O; Issakov J; Kollender Y; Inbar M; Bickels J; Meller I
Oncol Rep; 2002; 9(4):863-9. PubMed ID: 12066223
[TBL] [Abstract] [Full Text] [Related]
20. [Immunohistochemistry of biomolecular markers of early thyroid cancer].
Paltsev MA; Kogan EA; Tuntsova OI
Arkh Patol; 1997; 59(6):18-23. PubMed ID: 9483213
[TBL] [Abstract] [Full Text] [Related]
[Next]
